| Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective, multicentre, nationwide cohort KB Gecse, BD Lovász, K Farkas, J Banai, L Bene, B Gasztonyi, ... Journal of Crohn's and Colitis 10 (2), 133-140, 2016 | 178 | 2016 |
| Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in … LS Kiss, T Szamosi, T Molnar, P Miheller, L Lakatos, A Vincze, K Palatka, ... Alimentary pharmacology & therapeutics 34 (8), 911-922, 2011 | 152 | 2011 |
| Growth factors in ulcer healing: lessons from recent studies S Szabo, Á Vincze Journal of Physiology-Paris 94 (2), 77-81, 2000 | 139 | 2000 |
| Prospective, multicentre, nationwide clinical data from 600 cases of acute pancreatitis A Párniczky, B Kui, A Szentesi, A Balázs, Á Szűcs, D Mosztbacher, ... PLoS One 11 (10), e0165309, 2016 | 125 | 2016 |
| Growth factors: new ‘endogenous drugs’ for ulcer healing S Szabo, S Kusstatscher, G Sakoulas, Z Sandor, A Vincze, M Jadus Scandinavian journal of gastroenterology 30 (sup210), 15-18, 1995 | 114 | 1995 |
| Vascular approach to gastroduodenal ulceration: new studies with endothelins and VEGF. S Szabo, A Vincze, Z Sandor, M Jadus, Z Gombos, A Pedram, E Levin, ... Digestive diseases and sciences 43 (9 Suppl), 40S-45S, 1998 | 106 | 1998 |
| Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to … P Varjú, N Farkas, P Hegyi, A Garami, I Szabó, A Illés, M Solymár, ... PLoS One 12 (8), e0182942, 2017 | 87 | 2017 |
| Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles J Kun, I Szitter, Á Kemény, A Perkecz, L Kereskai, K Pohóczky, Á Vincze, ... PloS one 9 (9), e108164, 2014 | 82 | 2014 |
| Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal … A Dömötör, Z Peidl, Á Vincze, B Hunyady, J Szolcsányi, L Kereskay, ... Inflammopharmacology 13 (1), 161-177, 2005 | 78 | 2005 |
| Four response stages of capsaicin‐sensitive primary afferent neurons to capsaicin and its analog: Gastric acid secretion, gastric mucosal damage and protection G Mózsik, Á Vincze, J Szolcsányi Journal of gastroenterology and hepatology 16 (10), 1093-1097, 2001 | 62 | 2001 |
| Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta‐analysis and systematic review B Erőss, N Farkas, Á Vincze, B Tinusz, L Szapáry, A Garami, M Balaskó, ... Helicobacter 23 (4), e12504, 2018 | 39 | 2018 |
| Prediction of short-and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play the more … L Gonczi, Z Vegh, PA Golovics, M Rutka, KB Gecse, R Bor, K Farkas, ... Journal of Crohn's and Colitis 11 (6), 697-705, 2017 | 37 | 2017 |
| Long-term efficacy, safety, and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort L Gonczi, KB Gecse, Z Vegh, Z Kurti, M Rutka, K Farkas, PA Golovics, ... Inflammatory bowel diseases 23 (11), 1908-1915, 2017 | 36 | 2017 |
| Decrease of serum carotenoids in Crohn's disease G Rumi Jr, I Szabó, Á Vincze, Z Matus, G Tóth, G Mózsik Journal of Physiology-Paris 94 (2), 159-161, 2000 | 34 | 2000 |
| Meta-analysis of the long term success rate of different interventions in benign biliary strictures O Huszár, B Kokas, P Mátrai, P Hegyi, E Pétervári, Á Vincze, G Pár, ... PloS one 12 (1), e0169618, 2017 | 32 | 2017 |
| Failure of prostacyclin, β-carotene, atropine and cimetidine to produce gastric cyto-and general mucosal protection in surgically vagotomized rats G Mňzsik, Ŕ Kirŕly, M Garamszegi, T Jŕvor, L Nagy, G Sütő, G Tňth, ... Life sciences 49 (19), 1383-1389, 1991 | 32 | 1991 |
| Biosimilar infliximab in inflammatory bowel diseases: first interim results from a prospective nationwide observational cohort K Gecse, K Farkas, B Lovasz, J Banai, L Bene, B Gasztonyi, P Golovics, ... Zeitschrift für Gastroenterologie 53 (05), A11, 2015 | 31 | 2015 |
| Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis FY Al-Marzoqee, G Khoder, H Al-Awadhi, R John, A Beg, A Vincze, ... International journal of oncology 41 (5), 1733-1743, 2012 | 29 | 2012 |
| Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease: a meta-analysis P Sarlos, K Szemes, P Hegyi, A Garami, I Szabo, A Illes, M Solymar, ... Journal of Crohn's and Colitis 12 (4), 489-498, 2018 | 27 | 2018 |
| Efficacy and safety of adalimumab in ulcerative colitis refractory to conventional therapy in routine clinical practice A Bálint, K Farkas, K Palatka, L Lakner, P Miheller, I Rácz, G Hegede, ... Journal of Crohn's and Colitis 10 (1), 26-30, 2016 | 27 | 2016 |
Peter HegyiProfessor of Medicine, University of Pécs (PTE, full time) & Szeged (SZTE, part time), HungaryVerified email at med.u-szeged.hu
